Peripheral neuropathy remains one of the most disabling long-term complications of diabetes mellitus and chemotherapy. Conventional treatment primarily focuses on symptom management rather than restoration of damaged peripheral nerves. This clinical case presents the outcome of a multimodal regenerative medicine protocol utilizing stem cell therapy, exosomes, neurotrophic biologics, mitochondrial support, and prolonged home-based regenerative treatment in a patient with advanced peripheral neuropathy.

Severe Peripheral Neuropathy After Chemotherapy and Diabetes: A Clinical Case

Patient Profile

---

Medical History

John had lived with Type 2 diabetes for many years before being diagnosed with prostate cancer. Following chemotherapy, he gradually developed symptoms consistent with chemotherapy-induced peripheral neuropathy (CIPN), superimposed on diabetic neuropathy.

Over the next several years, neurological deterioration continued despite conventional supportive care.

Symptoms progressively worsened and included:

• Progressive numbness of both feet
• Burning neuropathic pain
• Loss of vibration sensation
• Severe muscle weakness
• Difficulty walking
• Poor balance
• Frequent unpredictable falls
• Multiple traumatic injuries related to instability
• Marked reduction in independence
• Fear of walking without assistance

By the time of presentation, the patient’s condition had reached an advanced stage characterized by chronic axonal degeneration and significant microvascular dysfunction affecting the peripheral nervous system.

---

Initial Clinical Assessment

The neurological examination demonstrated evidence of advanced sensorimotor neuropathy involving both lower extremities.

Major findings included:

• Severe sensory loss below the knees
• Reduced proprioception
• Decreased ankle reflexes
• Bilateral muscle weakness
• Significant gait instability
• Impaired coordination
• High fall risk
• Reduced walking endurance

The patient reported that every year the disease progressed despite medications and rehabilitation.

---

Therapeutic Strategy

Because the pathology involved multiple mechanisms—including neuronal degeneration, impaired microcirculation, mitochondrial dysfunction, chronic inflammation, and reduced neurotrophic signaling—a multimodal regenerative protocol was selected.

The treatment consisted of:

• Four-day intensive regenerative therapy
• Six-week home-based regenerative continuation program

The objective was not only symptom reduction but also biological stimulation of peripheral nerve repair and vascular regeneration.

---

In-Clinic Regenerative Treatment (4 Days)

---

Intranasal Neuroregenerative Support

To prolong regenerative signaling after intravenous therapy, the patient received an intranasal neuroregenerative protocol consisting of:

• Neurotrophin Biological Complex
• Neural Exosome Intranasal Spray

The intranasal route was selected because it allows biologically active molecules to access the central nervous system through the olfactory and trigeminal pathways, bypassing the blood-brain barrier and supporting sustained neuroregenerative signaling.

 

---

Home-Based Regenerative Support Program (6 Weeks)

Peripheral nerve regeneration is inherently slow. Long-standing diabetic microangiopathy and chronic axonal degeneration cannot be reversed during a four-day treatment alone.

Therefore, the patient continued a structured six-week regenerative program designed to maintain the biological environment established during the intensive phase.

The home protocol included:

• Lyophilized Stem Cell Complex
• Neural Secretome
• Neurotrophin + Neural Exosome Intranasal Spray

The objectives of prolonged therapy included:

• continuous paracrine signaling
• support of endogenous stem cell activity
• enhancement of angiogenesis
• prolonged neurotrophic stimulation
• mitochondrial support
• ongoing peripheral nerve remodeling
• promotion of Schwann cell activity

Clinical Outcomes

Functional improvement became noticeable during the first several weeks following treatment and continued throughout the home-based regenerative program.

The patient reported:

• substantial improvement in walking confidence
• increased lower limb strength
• better balance
• fewer episodes of stumbling
• elimination of unexpected falls
• improved endurance
• improved sensation in both feet
• increased independence in daily activities

No serious treatment-related adverse events were reported during therapy.

---

Functional Comparison: Before vs After Treatment

---

Estimated Neuropathy Assessment Scores

---

Biological Rationale

Peripheral neuropathy develops through multiple overlapping pathological mechanisms, including:

• chronic inflammation
• oxidative stress
• microvascular ischemia
• mitochondrial dysfunction
• Schwann cell degeneration
• impaired axonal transport
• reduced neurotrophic signaling

The multimodal regenerative protocol was designed to address these mechanisms simultaneously.

Proposed mechanisms of action include:

• stimulation of endogenous repair pathways
• enhancement of angiogenesis
• improvement of microvascular perfusion
• support of neuronal metabolism
• promotion of Schwann cell activity
• secretion of regenerative growth factors
• reduction of neuroinflammation
• support of axonal regeneration
• restoration of mitochondrial function

Chemotherapy-induced peripheral neuropathy combined with diabetic neuropathy represents one of the most difficult neurological conditions to manage. Conventional therapies—including gabapentinoids, antidepressants, analgesics, physical therapy, and vitamin supplementation—typically provide symptomatic relief without reversing structural nerve damage.

This case illustrates the potential of a comprehensive regenerative strategy aimed at supporting multiple biological pathways involved in peripheral nerve repair. The integration of stem cells, extracellular vesicles, neurotrophic signaling molecules, endothelial cells, mitochondrial support, and prolonged home-based regenerative therapy was associated with meaningful functional improvements, particularly in balance, gait, muscle strength, and fall prevention.

This case demonstrates the potential role of a multimodal regenerative medicine protocol in a patient with severe chronic peripheral neuropathy associated with diabetes and chemotherapy.

Following four days of intensive biological therapy and six weeks of continued regenerative support, the patient experienced clinically meaningful improvements in mobility, muscle strength, balance, sensory function, and independence, while eliminating recurrent falls.

Although further controlled research is required, this integrated regenerative strategy represents a promising investigational approach for patients with advanced peripheral neuropathy who have experienced limited benefit from conventional treatment.